F/m Emerald Life Sciences Innovation ETF LFSC

Medalist Rating as of | See Emerald Investment Hub

Morningstar’s Analysis LFSC

Will LFSC outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

F/m Emerald Life Sciences Innovation ETF holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LFSC

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings55.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Replimune Group Inc

11.1514M
Healthcare

LivaNova PLC

7.4110M
Healthcare

Cogent Biosciences Inc

5.757M
Healthcare

Travere Therapeutics Inc Ordinary Shares

5.637M
Healthcare

BillionToOne Inc Ordinary Shares - Class A

4.686M
Healthcare

Guardant Health Inc

4.526M
Healthcare

Veradermics Inc

4.246M
Healthcare

Spyre Therapeutics Inc

4.165M
Healthcare

Corcept Therapeutics Inc

3.915M
Healthcare

United Therapeutics Corp

3.655M
Healthcare

Sponsor Center